Utility of

PSMA PET/CT biochemical recurrence bombesin PET/CT prostate cancer

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
01 Aug 2024
Historique:
received: 03 04 2024
accepted: 05 06 2024
medline: 2 8 2024
pubmed: 2 8 2024
entrez: 1 8 2024
Statut: aheadofprint

Résumé

Despite a high detection rate of

Identifiants

DOI: 10.2967/jnumed.124.267881 PMID: 39089814
pubmed: 39089814
pii: jnumed.124.267881
doi: 10.2967/jnumed.124.267881
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Sherrington Li (S)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.

Andrew Nguyen (A)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.
St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

William Counter (W)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.

Nikeith C John (NC)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.

Jeremiah De Leon (J)

Genesis Cancer Care, Sydney, New South Wales, Australia.

George Hruby (G)

Genesis Cancer Care, Sydney, New South Wales, Australia.
Department of Radiation Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.

Anthony M Joshua (AM)

Kinghorn Cancer Care Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia.
Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Phillip Stricker (P)

Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Department of Urology, St. Vincent's Hospital, Sydney, New South Wales, Australia.
Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia; and.

Megan Crumbaker (M)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.
St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Garvan Institute of Medical Research, Sydney, New South Wales, Australia.

Narjess Ayati (N)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.
St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Garvan Institute of Medical Research, Sydney, New South Wales, Australia.

Lyn Chan (L)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.

Zahra Sabahi (Z)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.

Mina Swiha (M)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.
Nuclear Medicine Division, Department of Medical Imaging, University of Western Ontario, London, Ontario, Canada.

Andrew Kneebone (A)

Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.

Keith Wong (K)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.

Victor Liu (V)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.

Shikha Sharma (S)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.

Shikha Agrawal (S)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.
Kinghorn Cancer Care Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia.
Garvan Institute of Medical Research, Sydney, New South Wales, Australia.

Louise M Emmett (LM)

Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia; louise.emmett@svha.org.au.
St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Garvan Institute of Medical Research, Sydney, New South Wales, Australia.

Classifications MeSH